Biologics have accelerated to the forefront of the US pharmaceutical industry in the past few years, with ever-increasing demand for these large molecule products - but as we move towards more novel targets, how can we overcome the technical & regulatory challenges that come alongside this?

Our Biologics US Congress featuring the Proteins & Antibodies and ADC Discovery & Development programs, sets out to answer this question - over 6 tracks, uncover the next generation of biologics research, from novel engineering strategies to enhance antibody function & AI-driven antibody design to optimizing ADCs and utilizing these beyond just oncology. This revamped program will be packed with interactivity, networking opportunities and exclusive talks to equip you with the knowledge and connections needed to inform your pipeline and ensure the success of your R&D.